187 results
424B3
PBLA
Panbela Therapeutics, Inc.
15 May 24
Prospectus supplement
8:29pm
-looking statements,” including within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. When
424B3
PBLA
Panbela Therapeutics, Inc.
15 May 24
Prospectus supplement
8:27pm
-looking statements,” including within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. When
424B3
PBLA
Panbela Therapeutics, Inc.
15 May 24
Prospectus supplement
8:24pm
-looking statements,” including within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. When
424B3
PBLA
Panbela Therapeutics, Inc.
15 May 24
Prospectus supplement
8:22pm
-looking statements,” including within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. When
424B3
PBLA
Panbela Therapeutics, Inc.
15 May 24
Prospectus supplement
8:21pm
-looking statements,” including within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. When
424B3
9q3vfagfl2tiqbow6
15 May 24
Prospectus supplement
8:19pm
424B3
sa90 5xotcir2czr4
15 May 24
Prospectus supplement
8:17pm
DEFR14A
7gy 9bcpm3de0p2
6 May 24
Revised proxy
4:11pm
DEFA14A
tu8b7p
25 Apr 24
Additional proxy soliciting materials
4:36pm
8-K
u1lcw5vk
25 Apr 24
Entry into a Material Definitive Agreement
4:35pm
8-K
EX-99.1
yknbdkc
22 Apr 24
Panbela Therapeutics Announces Interim Data Analysis for ASPIRE Trial Pushed to Q1 2025
8:02am
POS AM
0qf5p82pz4 i8g8m
29 Mar 24
Prospectus update (post-effective amendment)
5:08pm
8-K
EX-99.1
t0dbuo1 gfdgx76o
26 Mar 24
Panbela Provides Business Update and Reports Q4 and FY 2024 Financial Results
4:12pm